Ferric carboxymaltose for anemia in Crohn's disease patients at a tertiary center: A retrospective observational cohort study.

World journal of clinical cases(2023)

引用 0|浏览3
暂无评分
摘要
This study demonstrated that FCM is an important therapeutic strategy for treating IDA in CD patients, achieving satisfactory results in refractory cases.
更多
查看译文
关键词
Ferric carboxymaltose, Iron deficiency anemia, Crohn's disease, Inflammatory bowel disease, Anemia, Clinical management
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要